Cellectis S.A. current report, Q2 FY2021

Cellectis S.A. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K, filed on May 6, 2021, by Cellectis S.A., a foreign private issuer based in Paris, France, incorporates by reference the company's interim report for the three-month period ended March 31, 2021 (Exhibit 99.1).

Key Financial Metrics

The provided filing text serves as a cover document and does not contain specific financial data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this text. The filing text does not provide a clear value for these metrics.

Material Changes

No material changes versus the prior comparable period are detailed in the provided text, as the specific interim report content is referenced but not included.

Guidance, Outlook, and Risks

The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are contained within the referenced Exhibit 99.1.

Investor Verification Checklist

  • Review Exhibit 99.1 (Interim Report for the three months ended March 31, 2021) for actual financial performance data.
  • Verify the incorporation of this report into registration statements on Form F-3 (No. 333-238881) and Form S-8 (Nos. 333-204205, 333-214884, 333-222482, and 333-227717).
  • Confirm the company's status as a filer of Form 20-F annual reports.